Ian S. Goldlust

Internal Medicine

622 W 168th St
New York, NY 10032

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Prenatal Cell-Free DNA Sequencing and Intrahepatic Cholangiocarcinoma.

Prenatal Cell-Free DNA Sequencing and Intrahepatic Cholangiocarcinoma.

Journal: JCO precision oncology

Published: June 11, 2025

Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.

Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.

Journal: Nature medicine

Published: April 15, 2025

Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer.

Prenatal cfDNA Sequencing and Incidental Detection of Maternal Cancer.

Journal: The New England journal of medicine

Published: January 08, 2025

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.

Journal: Nature medicine

Published: December 12, 2024

Incidental Detection of Maternal Cancer Following Cell-Free DNA Screening for Fetal Aneuploidies.

Incidental Detection of Maternal Cancer Following Cell-Free DNA Screening for Fetal Aneuploidies.

Journal: Clinical chemistry

Published: June 13, 2024

PARP inhibitors in ovarian cancer.

PARP inhibitors in ovarian cancer.

Journal: Seminars in oncology

Published: May 11, 2023

The spectrum of cell death in sarcoma.

The spectrum of cell death in sarcoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 03, 2023

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer.

Matrix Drug Screen Identifies Synergistic Drug Combinations to Augment SMAC Mimetic Activity in Ovarian Cancer.

Journal: Cancers

Published: October 18, 2020

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model.

Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model.

Journal: Cancers

Published: May 18, 2020

Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.

Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.

Journal: PLoS computational biology

Published: December 09, 2016

mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening.

mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening.

Journal: Scientific reports

Published: May 03, 2016

Large-scale pharmacological profiling of 3D tumor models of cancer cells.

Large-scale pharmacological profiling of 3D tumor models of cancer cells.

Journal: Cell death & disease

Published: October 21, 2015

Showing 1-12 of 20

Last Updated: 09/26/2026